| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Bolzon Bradley J Phd is a Director, 10% Owner at GLUE, with reported holdings spanning 3 companies. Recent filings cover 9 purchases and 194 sales. Those positions are worth an estimated $59.0M at current prices.
Our model assigns Bolzon Bradley J Phd a strong insider score of 75/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +33.1%.
Bolzon Bradley J Phd's largest disclosed position is in GLUE as Director, 10% Owner, worth about $39.9M. Net of sales, the recent Form 4 record there shows accumulation of 157,895 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 10,000 | $126.43 | $1,264,347.53 | -6.3% | -23.5% | -33.4% | |
| Jun 29, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 47,536 | $149.49 | $7,106,341.02 | -100% | -22.1% | -58.1% | |
| Jun 28, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 30,375 | $152.48 | $4,631,582.53 | -16.1% | -22.7% | -58.3% | |
| Jun 28, 2021 | GLUE Monte Rosa Therapeutics, Inc. | Director, 10% Owner | Buy | 157,895 | $19.00 | $3,000,005.00 | +8.1% | +28.8% | -49.9% | |
| Jun 11, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 10,000 | $126.61 | $1,266,118.41 | -32.9% | -4.4% | -49.8% | |
| Mar 22, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 30,374 | $132.37 | $4,020,666.79 | -50.0% | -2.5% | -49.2% | |
| Feb 19, 2021 | CRSP Crispr Therapeutics AG | Director | Sell | 171,003 | $149.11 | $25,497,839.62 | -50.3% | - | - | |
| Dec 16, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 14,041 | $149.28 | $2,096,076.60 | -4.0% | - | - | |
| Dec 10, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 33,000 | $143.35 | $4,730,447.90 | -9.5% | - | - | |
| Dec 7, 2020 | CRSP Crispr Therapeutics AG | Director | Sell | 171,004 | $154.53 | $26,424,505.04 | -33.0% | - | - |